| Teresa Jacobs-castano Pc | |
|
502 S 4th St Laramie WY 82070-3704 | |
| (307) 755-1000 | |
| (307) 742-9717 |
| Full Name | Teresa Jacobs-castano Pc |
|---|---|
| Speciality | Social Worker |
| Location | 502 S 4th St, Laramie, Wyoming |
| Authorized Official Name and Position | Teresa Jacobs-castano (OWNER) |
| Authorized Official Contact | 3077551000 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa Jacobs-castano Pc 502 S 4th St Laramie WY 82070-3704 Ph: (307) 755-1000 | Teresa Jacobs-castano Pc 502 S 4th St Laramie WY 82070-3704 Ph: (307) 755-1000 |
| NPI Number | 1164650917 |
|---|---|
| Provider Enumeration Date | 06/30/2009 |
| Last Update Date | 03/21/2019 |
| Medicare PECOS PAC ID | 0244377323 |
|---|---|
| Medicare Enrollment ID | O20091021000772 |
News Archive
A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford's early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.
Oxygen Biotherapeutics, Inc. announced today that the company's common stock will begin trading on the Swiss SIX Exchange with the opening of trading tomorrow, Tuesday, June 29, 2010. The company's shares will trade under the same ticker symbol, OXBT, as they currently do on the NASDAQ Capital Market.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164650917 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW 176 (Wyoming) | Primary |
| Provider Name | Teresa Jacobs Castano |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1821215286 PECOS PAC ID: 6002953189 Enrollment ID: I20091021000726 |
News Archive
A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford's early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.
Oxygen Biotherapeutics, Inc. announced today that the company's common stock will begin trading on the Swiss SIX Exchange with the opening of trading tomorrow, Tuesday, June 29, 2010. The company's shares will trade under the same ticker symbol, OXBT, as they currently do on the NASDAQ Capital Market.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
News Archive
A study published in the Journal of Occupational and Environmental Medicine from researchers at Henry Ford Health System has found that Henry Ford's early implementation of a universal mask policy in the COVID-19 pandemic was associated with reducing the risk of healthcare workers at Henry Ford acquiring COVID-19.
Oxygen Biotherapeutics, Inc. announced today that the company's common stock will begin trading on the Swiss SIX Exchange with the opening of trading tomorrow, Tuesday, June 29, 2010. The company's shares will trade under the same ticker symbol, OXBT, as they currently do on the NASDAQ Capital Market.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
Cathedral Home For Children Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4989 N 3rd St, Laramie, WY 82072 Phone: 307-745-8997 | |
Pendley And Associates Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1277 N 15th St, Laramie, WY 82072 Phone: 307-742-6222 | |
Ark Regional Services, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1150 N 3rd St, Laramie, WY 82072 Phone: 307-742-6641 Fax: 307-742-9203 | |
Overcomer Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 265 N 4th St, Laramie, WY 82072 Phone: 307-399-0791 | |
Cathedral Home For Children Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4989 N 3rd St, Laramie, WY 82072 Phone: 307-745-8997 Fax: 307-742-6146 | |
Integrative Well-being Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1622 Shield St, Laramie, WY 82072 Phone: 307-760-5450 | |
Aktos Analytics, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1465 N 4th St, Suite #119, Laramie, WY 82072 Phone: 307-721-0700 |